Efficacy of Intrathoracic Intercostal Nerve Block on Postoperative Acute and Chronic Pains of Patients Undergoing Video-Assisted Thoracoscopic Surgery
Xiaoning Zhao,Xiaoqian Li,Ying Wang,Weijie Xiao,Baihui Zhang,Xin Meng,Xijia Sun
DOI: https://doi.org/10.2147/JPR.S369042
IF: 2.8319
2022-08-07
Journal of Pain Research
Abstract:Xiaoning Zhao, Xiaoqian Li, Ying Wang, Weijie Xiao, Baihui Zhang, Xin Meng, Xijia Sun The Department of Anesthesiology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China Correspondence: Xijia Sun, The Department of Anesthesiology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China, Tel +86 15840015620, Email Background: Patients undergoing video-assisted thoracoscopic surgery (VATS) frequently suffered postoperative acute and chronic pains. In recent years, intrathoracic intercostal nerve block (INB) is regularly used thanks to its safety and accuracy, especially under the circumstance of lacking ultrasound or in face of the contraindications of the thoracic paravertebral block (TPVB). However, clinical evidence of comparing TPVB and INB for pain management after VATS has been limited and the observation of the chronic pain has been less than clear. Methods: A total of 180 patients undergoing VATS were randomly divided into three groups: A single multi-point paravertebral nerve block (Group P), intrathoracic intercostal nerve block (Group I), and general anesthesia without any regional block (Group C). Postoperative acute pain was scored at rest and coughing by the Visual Analog Scale (VAS) for recording 24h, 48h and 72h after VATS. All patients were interviewed 1, 3 and 6 months after the surgery to investigate both the incidence and intensity of chronic pains. Results: There were significantly less incidence and intensity of acute pain in Group P and Group I, compared to those in Group C. The patients in Group I showed the least incidence and intensity of chronic pain after 3 months compared with those in Group P and Group C. There are 89 of 98 patients suffering pains after 1 month, which grew into chronic pains after 3 months and 78 of them still suffered chronic pains even after 6 months. Conclusion: The intrathoracic INB offers excellent relief from acute and chronic pains, which does as effectively as TPVB. Besides, one-month postoperative pain could increase the risk of a chronic one. Keywords: video-assisted thoracoscopic surgery, acute pain, chronic pain, intrathoracic intercostal nerve block, paravertebral nerve block The video-assisted thoracoscopic surgery (VATS) is a less-invasive treatment for lung cancer, but many patients still suffer moderate and severe postoperative pain from it. 1,2 As the most representative region block, thoracic paravertebral block (TPVB) has been confirmed in the clinic; however, its limitations include the dependency on ultrasound and the not-target spaces spread of local anesthetic. 2,3 In recent years, the intrathoracic intercostal nerve block (INB) is frequently applied for its safety and accuracy in pain relief, especially when lacking ultrasound or in face of the contraindications of TPVB. 4 It has been confirmed to have increased patients' satisfaction with postoperative analgesia after VATS. 4,5 However, clinical evidence comparing TPVB and INB for pain management after VATS has been limited, while the INB efficacy revealed in some experiments has been controversial. 6,7 Furthermore, a considerable number of previous studies had already confirmed the acute pain to be a predictor of the chronic one. Chronic Post-Surgical Pain (CPSP) is defined as the one persisting more than 3 months after the surgery which severely impairs patients' long-term outcomes and qualities of life. 5,8 However, little is known regarding the effects of different analgesic methods on long-term chronic pain. In terms of its Numerical Rating Scale (NRS) scores, few reports directly compared the efficacies of TPVB and INB. The incidence of chronic pain and its relationship with the early stage of pain are also unclear. Therefore, we conducted this study to confirm the efficacy of intrathoracic INB on postoperative acute and chronic pains of patients undergoing VATS to improve their long-term outcomes. The study was conducted under the principles of the Declaration of Helsinki. It was also approved by the Ethics Committee of Medical Science Research of the First Affiliated Hospital of China Medical University (Approval number: 2021–40-2) with written informed consents obtained from all participating subjects. The trial was registered before patient enrollment in the Chinese Clinical Trial Registry at www.chictr.org.cn (ChiCTR2100046730, principal investigator, Zhao Xiaoning, Date of registration: 2021/5/27). Subjects eligible for the study were 180 patients with lung cancer undergoing VATS in June 2021, aged 18–65 years with the American Society of Anesthesiologists (ASA)'s identified physical status of I–II. The exclusion criteria consisted of pre -Abstract Truncated-
clinical neurology